Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Karp

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Future research directions for the treatment of AMLJudith Karp
Therapeutic Advances in Hematology|May 17, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patientsKimberley Doucette, Judith Karp, Catherine Lai
British Journal of Haematology|June 26, 2003
Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial'B Douglas Smith, Judith Karp, Philip Burke
Journal of the National Cancer Institute|February 27, 2024
Genomic testing and patient rightsC Michael Jones, Judith Karp, Dena S Davis
Blood Cells, Molecules & Diseases|February 6, 2004
Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cellsAsit Nandi, Michael Tidwell, Judith Karp, et al.
Results and Problems in Cell Differentiation|November 18, 2017
Targeting TCTP with Sertraline and Thioridazine in Cancer TreatmentRobert Amson, Christian Auclair, Fabrice André, et al.
Hematology Reports|February 20, 2026
A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid LeukemiasBryan Chan, Eesha Balar, Seiichi Villalona, et al.
Leukemia Research|September 24, 2004
Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemiaAnna M Rice, Kathleen M Holtz, Judith Karp, et al.
Oncotarget|July 9, 2016
SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine modelsQing Wu, Aaron Bhole, Haiyan Qin, et al.
Nature|January 11, 2008
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNAWenqiang Yu, David Gius, Patrick Onyango, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Future research directions for the treatment of AMLJudith Karp
Therapeutic Advances in Hematology|May 17, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patientsKimberley Doucette, Judith Karp, Catherine Lai
British Journal of Haematology|June 26, 2003
Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial'B Douglas Smith, Judith Karp, Philip Burke
Journal of the National Cancer Institute|February 27, 2024
Genomic testing and patient rightsC Michael Jones, Judith Karp, Dena S Davis
Blood Cells, Molecules & Diseases|February 6, 2004
Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cellsAsit Nandi, Michael Tidwell, Judith Karp, et al.
Results and Problems in Cell Differentiation|November 18, 2017
Targeting TCTP with Sertraline and Thioridazine in Cancer TreatmentRobert Amson, Christian Auclair, Fabrice André, et al.
Hematology Reports|February 20, 2026
A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid LeukemiasBryan Chan, Eesha Balar, Seiichi Villalona, et al.
Leukemia Research|September 24, 2004
Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemiaAnna M Rice, Kathleen M Holtz, Judith Karp, et al.
Oncotarget|July 9, 2016
SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine modelsQing Wu, Aaron Bhole, Haiyan Qin, et al.
Nature|January 11, 2008
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNAWenqiang Yu, David Gius, Patrick Onyango, et al.
Pageof 3